Element Capital Management LLC Sarepta Therapeutics, Inc. Transaction History

Element Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $375,103 - $525,392	-3,253 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $28.7 Million - $61.5 Million	-399,997 Reduced 99.19%	3,253 $430,000
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $4.59 Million - $6.99 Million	85,020 Added 26.72%	403,250 $29.9 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $15.2 Million - $18.1 Million	318,230	318,230 $17.7 Million

557

85.6M

3.67M

1.75M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.